EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 8 filers reported holding EVAXION BIOTECH A S in Q3 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,646 | -69.9% | 43,774 | -54.5% | 0.00% | – |
| Q2 2023 | $125,081 | -6.8% | 96,216 | -19.0% | 0.00% | – |
| Q1 2023 | $134,156 | +79.2% | 118,722 | +185.4% | 0.00% | – |
| Q4 2022 | $74,880 | -90.7% | 41,600 | -86.4% | 0.00% | – |
| Q3 2022 | $803,000 | +113.6% | 305,200 | +58.3% | 0.00% | – |
| Q2 2022 | $376,000 | +6.5% | 192,800 | +66.5% | 0.00% | – |
| Q1 2022 | $353,000 | +42.3% | 115,800 | +107.6% | 0.00% | – |
| Q4 2021 | $248,000 | – | 55,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 122,000 | $238,000 | 0.28% |
| CITIGROUP INC | 2,941 | $6,000 | 0.00% |
| MORGAN STANLEY | 4,296 | $8,000 | 0.00% |
| Citadel Advisors | 333,100 | $650,000 | 0.00% |
| Citadel Advisors | 37,300 | $73,000 | 0.00% |
| Citadel Advisors | 83,586 | $163,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 192,800 | $376,000 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 339 | $1,000 | 0.00% |
| Steward Partners Investment Advisory, LLC | 1,000 | $2,000 | 0.00% |
| Renaissance Technologies | 11,600 | $22,000 | 0.00% |